Clinical response of clozapine as a treatment for delirious mania
Author(s) -
Nabeel Wahid,
Garwin Chin,
Andia H. Turner,
Alexis Seegan
Publication year - 2017
Publication title -
mental illness
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.239
H-Index - 10
eISSN - 2036-7465
pISSN - 2036-7457
DOI - 10.4081/mi.2017.7182
Subject(s) - mania , clozapine , electroconvulsive therapy , olanzapine , psychiatry , modalities , medicine , treatment modality , risperidone , bipolar disorder , schizophrenia (object oriented programming) , intensive care medicine , mood , social science , sociology
Delirious mania is an understudied psychiatric disorder with a mortality rate as high as 75%. Previous case studies suggest that electroconvulsive therapy (ECT) may be an effective treatment for delirious mania, though this procedure may not always be a viable option. We describe the case of a 20-year old patient, with no previous psychiatric history, who developed delirious mania over the course of four months. ECT was not a viable option for this patient due to his religious beliefs, so alternative treatment modalities were explored. After failing trials of risperidone and olanzapine, significant improvements in symptoms were exhibited with a trial of clozapine. We propose that clozapine may be an effective option in cases of delirious mania, when ECT is not a viable option. Additional research is still necessary to understand the pathology of this condition and potential treatment modalities
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom